2646. Incidence of Myelosuppression Related to Valganciclovir Prophylaxis in Solid-Organ Transplant Recipients at High Risk of CMV Disease

BACKGROUND: Valganciclovir (VGCV) prophylaxis in solid-organ transplant patients (SOT) is limited by myelotoxicity. We aimed to analyze the impact of VGCV prophylaxis on myelotoxicity and risk factors for its occurrence. METHODS: Retrospective single-center cohort study of adult CMV-seronegative rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Belga, Sara, Hernandez, Cristina, Kabbani, Dima, Cervera, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810729/
http://dx.doi.org/10.1093/ofid/ofz360.2324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810729/
http://dx.doi.org/10.1093/ofid/ofz360.2324

Ejemplares similares